Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Diseases × exemestane × Clear all

Phase

Phase 1 2 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Neoplasm Metastasis 2 Skin Diseases 1 Sexuality 1 Patient Acceptance of Health Care 1 Neoplasms 1 Breast Diseases 1 Breast Carcinoma In Situ 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 exemestane 1 Sodium Chloride 1 Everolimus 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡